| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
138,140,000 |
| Market
Cap: |
142.28(M) |
| Last
Volume: |
3,241,097 |
Avg
Vol: |
3,344,386 |
| 52
Week Range: |
$0.937 - $1.11 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 807 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
490,738 |
| Total Sell Value |
$0 |
$0 |
$0 |
$343,474 |
| Total People Sold |
0 |
0 |
0 |
7 |
| Total Sell Transactions |
0 |
0 |
0 |
19 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2005-05-18 |
4 |
B |
$4.80 |
$9,651 |
D/D |
2,000 |
29,576 |
2.81 |
- |
|
| Krassner Stuart Mitchell |
Director |
– • – |
2004-12-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
750 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2004-07-19 |
4 |
B |
$5.11 |
$10,220 |
D/D |
2,000 |
27,576 |
2.81 |
- |
|
| Kumaria Shyam K |
Vice President Finance |
• – – |
2004-07-16 |
4 |
B |
$5.10 |
$18,360 |
D/D |
3,600 |
4,000 |
2.74 |
- |
|
| Lenaz Luigi Md |
President Oncology Division |
• – – |
2004-06-21 |
4 |
B |
$5.39 |
$3,238 |
D/D |
600 |
36,790 |
2.66 |
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2004-06-21 |
4 |
B |
$5.40 |
$5,397 |
D/D |
1,000 |
25,576 |
2.81 |
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2004-06-10 |
4 |
B |
$6.75 |
$13,491 |
D/D |
2,000 |
24,576 |
2.81 |
- |
|
| Kumaria Shyam K |
Vice President FinanceOfficer |
• – – |
2003-12-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
400 |
|
- |
|
658 Records found
|
|
Page 27 of 27 |
|
|
